Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1524 participants
OBSERVATIONAL
2011-02-28
2011-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* pulmonary cancer
* pulmonary tuberculosis
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
AstraZeneca
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
György Losonczy, MD PHD
Role: PRINCIPAL_INVESTIGATOR
Semmelweis University Budapest Pulmonology Clinic
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Research Site
Adásztevel, Adásztevel, Hungary
Research Site
Ajka, Ajka, Hungary
Research Site
Albertirsa, Albertirsa, Hungary
Research Site
Baja, Baja, Hungary
Research Site
Balatonendréd, Balatonendréd, Hungary
Research Site
Békés, Bekes County, Hungary
Research Site
Budajenő, Budajenő, Hungary
Research Site
Budakeszi, Budakeszi, Hungary
Research Site
Budapest, Budapest, Hungary
Research Site
Békéscsaba, Békéscsaba, Hungary
Research Site
Celldömölk, Celldömölk, Hungary
Research Site
Dabas, Dabas, Hungary
Research Site
Debrecen, Debrecen, Hungary
Research Site
Dombóvár, Dombóvár, Hungary
Research Site
Dunaújváros, Dunaújváros, Hungary
Research Site
Edelény, Edelény, Hungary
Research Site
Eger, Eger, Hungary
Research Site
Encs, Encs, Hungary
Research Site
Esztergom, Esztergom, Hungary
Research Site
Gyula, Gyula, Hungary
Research Site
Gyöngyös, Gyöngyös, Hungary
Research Site
Győr, Győr, Hungary
Research Site
Hatvan, Hatvan, Hungary
Research Site
Hódmezővásárhely, Hódmezővásárhely, Hungary
Research Site
Kaposvár, Kaposvár, Hungary
Research Site
Kecskemét, Kecskemét, Hungary
Research Site
Kisbér, Kisbér, Hungary
Research Site
Kiskunfélegyháza, Kiskunfélegyháza, Hungary
Research Site
Kiskunhalas, Kiskunhalas, Hungary
Research Site
Komárom, Komárom, Hungary
Research Site
Körmend, Körmend, Hungary
Research Site
Lenti, Lenti, Hungary
Research Site
Miskolc, Miskolc, Hungary
Research Site
Monor, Monor, Hungary
Research Site
Mosdós, Mosdós, Hungary
Research Site
Mátraháza, Mátraháza, Hungary
Research Site
Mór, Mór, Hungary
Research Site
Nagykanizsa, Nagykanizsa, Hungary
Research Site
Nyíregyháza, Nyíregyháza, Hungary
Research Site
Paks, Paks, Hungary
Research Site
Pécs, Pécs, Hungary
Research Site
Sopron, Sopron, Hungary
Research Site
Szarvas, Szarvas, Hungary
Research Site
Szeged, Szeged, Hungary
Research Site
Szombathely, Szombathely, Hungary
Research Site
Székesfehérvár, Székesfehérvár, Hungary
Research Site
Tatabánya, Tatabánya, Hungary
Research Site
Tata, Tata, Hungary
Research Site
Tiszaújváros, Tiszaújváros, Hungary
Research Site
Törökbálint, Törökbálint, Hungary
Research Site
Törökszentmiklós, Törökszentmiklós, Hungary
Research Site
Veszprém, Veszprém megye, Hungary
Research Site
Zalaegerszeg, Zalaegerszeg, Hungary
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NIS-RHU-XXX-2011/1
Identifier Type: -
Identifier Source: org_study_id